Opthea to Present at UBS Ophthalmology Day
Ticker: OPTEY · Form: 6-K · Filed: Sep 30, 2024 · CIK: 1815620
Sentiment: neutral
Topics: event-announcement, ophthalmology
TL;DR
Opthea is presenting at the UBS Virtual Ophthalmology Day this September - expect updates.
AI Summary
Opthea Ltd announced its participation in the UBS Virtual Ophthalmology Day 2024, scheduled for September 2024. The company will present its latest advancements and strategic outlook in the ophthalmology sector. This event provides a platform for Opthea to engage with investors and industry peers.
Why It Matters
Participation in industry events like the UBS Ophthalmology Day allows Opthea to showcase its pipeline and engage with key stakeholders, potentially influencing investor perception and future funding.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in an event and does not contain material financial or operational changes.
Key Players & Entities
- Opthea Ltd (company) — Registrant
- UBS (company) — Event Host
- Virtual Ophthalmology Day 2024 (event) — Event Name
FAQ
What is the purpose of Opthea's participation in the UBS Virtual Ophthalmology Day?
Opthea will present its latest advancements and strategic outlook in the ophthalmology sector at the UBS Virtual Ophthalmology Day 2024.
When is the UBS Virtual Ophthalmology Day scheduled to take place?
The UBS Virtual Ophthalmology Day is scheduled for September 2024.
What form is this SEC filing?
This SEC filing is a Form 6-K.
What is Opthea Limited's principal executive office address?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Does Opthea file annual reports under Form 20-F or 40-F?
Opthea files annual reports under Form 20-F.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-09-30 06:03:05
Filing Documents
- opt_-_opthea_ubs_virtual.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 19KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-110160.txt ( ) — 210KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 09/30/2024